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 PEX19 is a predominantly cytosolic, 
farnesylated protein of mammalian and yeast 
cells that binds multiple peroxisome membrane 
proteins and is required for their correct 
targeting/insertion to the peroxisome 
membrane. Here we provide functional 
characterisation of Arabidopsis PEX19 
(AtPEX19), which is encoded by two genes that 
are expressed in all tissues and at all 
developmental stages of the plant. Like its yeast 
and mammalian counterparts AtPEX19 is 
predominantly cytosolic and binds the 
peroxisomal membrane protein AtPEX10. 
Farnesylation of AtPEX19 is not required for 
PEX10 binding. We further provide evidence 
that AtPEX19 is a dimer and that the dimer 
preferentially forms complexes with other 
proteins in vivo. Based on our data and that of 
others we propose a model for the recognition 
of peroxisomal membrane proteins by PEX19 
and their PEX3 dependent integration into the 
peroxisome membrane. 
 
 Peroxisomes are single-membrane bound 
metabolic organelles, found in virtually all 
eukaryotes. There are two conserved functions of 
peroxisomes found amongst evolutionary diverse 
organisms, namely β-oxidation of fatty acids and 
hydrogen peroxide metabolism. Other specialised 
roles depend on the organism and cell type. 
 Plant peroxisomes are involved in a range 
of important functions such as the mobilisation of 
storage reserves in germinating seedlings via β-
oxidation and the glyoxylate cycle [1], the salvage 
of carbon through photorespiration [2] and defence 
against oxidative stresses [3]. Plant peroxisomes 
are also implicated in the generation of a variety of 
significant hormones and other signalling 
molecules, including indole acetic acid [4], 
jasmonate [5, 6], nitric oxide and several reactive 
oxygen species [3].  It has also emerged that plant 
peroxisomes are involved in light regulated gene 
expression [7], embryogenesis [8, 9] and the 
breaking of seed dormancy [10]. 
 Although peroxisome function varies 
between species, the biogenesis of peroxisomes 
relies on a common class of conserved genes, 
referred to as PEX genes, which encode proteins 
termed peroxins. To date, over thirty peroxins have 
been identified. They are involved in peroxisomal 
matrix protein import, membrane biogenesis and 
organelle proliferation, although their exact 
mechanistic functions are still only partially 
understood. The mechanisms used for importing 
peroxisomal membrane proteins (PMPs) are 
distinct from those that translocate proteins into 
the peroxisomal matrix. Only three peroxins 
potentially play a role in PMP targeting: PEX3 
[11, 12], PEX16 [13, 14]; and PEX19 [15-18]. 
Recent observations in Saccharomyces cerevisiae 
have shown that an interaction between Pex3 and 
Pex19 is necessary for peroxisome biogenesis at 
the endoplasmic reticulum [19]. In cells deficient 
in any of these peroxins, PMPs are either degraded 
or mistargeted to other subcellular locations [11, 
20, 21]. 
 PEX19 has been identified as a candidate 
for both a chaperone [22] and  a receptor [21] for 
PMPs. Many pex19 mutants lack any detectable 
peroxisome membranes, or have low levels of 
PMPs which are mislocalised to the cytosol or 
mitochondria [11, 21]. However in pex19 mutants 
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of Y. lipolytica, H. polymorpha and P.pastoris, 
small vesicular structures similar in density to wild 
type peroxisomes and containing some matrix 
proteins, were found [17, 23, 24]. There is 
controversy regarding whether PEX19 
preferentially binds newly synthesised [25] or 
existing [22] PMPs, or whether it may even play a 
role in the assembly of protein complexes in the 
peroxisome membrane [26]. There is also 
disagreement as to whether PEX19 binds a region 
that contains peroxisomal targeting information 
(mPTS) and therefore functions as a PMP receptor 
[21, 25], or if PEX19 binding and PMP targeting 
are separable events [26, 27]. Recently, the Pex19p 
binding sites on several Saccharomyces PMPs 
have been experimentally determined and shown 
to be essential for correct targeting, providing 
strong evidence for a receptor function for Pex19p 
[28]. Targeting of PMPs also requires at least one 
transmembrane domain (TMD) in addition to the 
PEX19 binding site, in order to bring about correct 
localisation to peroxisomes [28]. Thus an mPTS 
has two functionally distinct domains, a PEX19 
binding site and a TMD.  
The cellular distribution of PEX19 
(predominantly cytosolic with a small amount 
associated with peroxisomes) is consistent with a 
function in shuttling PMPs from the cytosol to the 
peroxisome membrane. The integral peroxisome 
membrane protein PEX3 has been shown to act as 
a receptor for PEX19 [29]. Membrane association 
of PEX19 has been suggested to be through 
farnesylation of the C-terminus at a conserved 
prenylation motif (CaaX box). However, there are 
conflicting reports as to whether farnesylation of 
PEX19 is important for function [16, 17, 21, 27]. 
PEX19 has a broad specificity, binding to many 
PMPs and domain mapping of the protein [30-32] 
has led to the suggestion that it may bind PMPs in 
multiple places for multiple functions [30]. 
 We have characterised a homologue of 
PEX19 from Arabidopsis thaliana. We show that 
AtPEX19 is predominately cytosolic with the 
membrane associated fraction partly peroxisomal. 
In vitro translated and recombinant AtPEX19 
binds to the PMP, AtPEX10, and the recombinant 
protein has a two-domain structure similar to the 
human protein, thus suggesting that structure and 
function is conserved between plants and humans. 
We also provide evidence that AtPEX19 is a dimer 
in vitro and that the dimeric form is preferentially 
cross-linked to other proteins in vivo: a novel 
feature not yet demonstrated in yeast or 
mammalian PEX19. 
 
EXPERIMENTAL PROCEDURES 
 
Constructs for expression of recombinant PEX19 
and GST-Pex10267-381 - Molecular biology methods 
were carried out according to Sambrook & Russell 
[33]. EST clone ATTS4952 encoding AtPEX19-1 
was obtained from Dr Thierry Desprez, INRA, 
Versailles, France. The PEX19-1 (At3g03490) 
reading frame was amplified by PCR using 
primers 5’-
GCGGAATTCGGCGAACAGTCACACCGAT-3’ 
and  
5’-
CGCGCCTCGAGTCACATGATACAGCAATT-
3’ that introduced an EcoRI site adjacent to the 
second amino acid (Ala) and an XhoI site down 
stream of the termination codon, and recloned into 
pET28(b) (Novagen) cut with the same restriction 
enzymes. The encoded protein is referred to as 
His6T7PEX19 as it contains both the His and T7 
tags N-terminal to PEX19 and has a theoretical pI 
of 5.00 and Mw of 31,842. A similar construct 
where PEX19 was cloned into the NheI-SacI sites 
of pET28(a) was obtained from Dr Susanna 
Cristobal, Uppsala University Sweden. This 
encodes a protein we refer to as His6PEX19 as it 
lacks the T7 tag and has a theoretical pI of 5.00 
and Mw of 30,482. When expressed in E. coli 
His6T7PEX19 is insoluble but can be solubilised 
and refolded whereas His6PEX19 is expressed in a 
soluble form. His6T7PEX19 was used for antibody 
production and the co-immunoprecipitation 
experiment. His6PEX19 was used in all other 
experiments.  
 The carboxyl terminal region  of AtPEX10 
(At2g26350) cDNA was amplified using Gateway 
primers (forward strand 5’-
GGGGACAAGTTTGTACAAAAAAGCAGGCT
TCATGCGTCGGAGTAATTTGTCA-3’ and 
reverse strand 3’-
GGGGACCACTTTGTACAAGAAAGCTGGGT
TCTAAAAATCAGAATGATACAA-5’) with 
PfuTurbo proofreading DNA polymerase 
(Stratagene). The PCR product was inserted in the 
Gateway donor vector pDONR201 (Invitrogen) via 
the Gateway BP reaction and then transferred into 
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pDEST15 (Invitrogen) via the Gateway LR 
reaction 
Bacterial culture for protein expression- 
His6PEX19 and GST-Pex10267-381 were expressed 
in E. coli BL21 (DE3) pLysS cells (Novagen) and 
His6T7PEX19 in BL21 (DE3) Codon Plus RIL 
cells (Invitrogen), as described (Novagen pET 
hand book 10th edition (www.novagen.com). The 
majority of the His6T7PEX19 protein was 
insoluble, and so the inclusion bodies were 
solubilised in 20 mM Na phosphate buffer pH 7.5, 
10 mM imidazole, 0.5M NaCl, 8M urea (50 μl/ml 
culture) and solubilised protein was purified by 
passage over a Ni2+ column (GE Healthcare) 
according to the manufacturer’s instructions. The 
purified protein was dialysed overnight at 4oC 
against 20 mM Na phosphate buffer pH 7.5. The 
purified protein was used to raise polyclonal 
antibodies in rabbits (Scottish Antibody 
Production Unit, Carluke, Scotland). His6PEX19 
was soluble and was purified on a 5ml Hi-Trap 
nickel affinity column (GE Healthcare) according 
to the manufacturers instructions. For molecular 
weight estimation using gel filtration 
chromatography, 1.5 ml of purified His6PEX19 (10 
mg/ml) was applied in 50 mM NaCl, 20 mM Tris 
pH 8.0, to a Superdex 75 26/60 column (GE 
Healthcare), pre-equilibrated in the same buffer.  
For the production of soluble GST-Pex10267-381, 
when absorbance of the culture at 600 nm reached 
0.4, it was heat-shocked at 45ºC for 20 minutes 
then cooled rapidly to 18 ºC. IPTG was added to 
0.5 mM and the culture incubated at 18ºC, 200 
rpm for a further 4 hours.  
Isolation of His6PEX19-GST-Pex10267-381 complex- 
Cell pellets from 400 ml cultures of 
BL21(DE3)pLysS expressing  His6PEX19 and 
BL21(DE3)pLysS expressing GST-Pex10267-381  
were individually resuspended in 10 ml PBS, 1 
mM DTT containing 5 mg lysozyme and a 
COMPLETETM protease inhibitor tablet (Roche). 
The suspensions were incubated for 20 minutes on 
ice then sonicated 6 times for 30 seconds on/30 
seconds off, before centrifugation at 20,000g for 
30 minutes at 5ºC. The supernatants were applied 
to a 1 ml glutathione agarose column (Sigma) 
either singly or as a mixture. The column was 
washed with 20 ml PBS and bound proteins eluted 
stepwise with PBS containing 10 mM reduced 
glutathione in 2 ml fractions. The fractions were 
examined by SDS-PAGE and Western blot. 
PEX19 was visualised using antisera raised to 
His6T7PEX19 at a 1:10,000 dilution followed by 
goat anti-rabbit IgG-horse radish peroxidase 
(Sigma, 1:10,000 dilution) with enhanced 
chemiluminescent detection. 
Cross-linking Arabidopsis cells in vivo with 
formaldehyde- Arabidosis cells suspension [34] 
were grown in 100  ml MS medium (4.43g/L, 
sucrose 30g/L, NAA 0.5mg/L, and Kinetin 
0.05mg/L, pH, 5.8) at 24ºC under dim light with a 
16-hour photoperiod in a rotary shaker at 110 rpm. 
The cells were split every seven days at a 1:10 
dilution into the same media. A 100 ml culture was 
centrifuged at 1000 rpm, the cell pellet was 
resuspended in PBS containing 1% formaldehyde 
and incubated at room temperature for 1 hour. To 
quench the reaction glycine was added to a final 
concentration of 300 mM in PBS and incubated for 
a further 30 minutes. The cells were centrifuged at 
1000 rpm and washed by re-suspension in PBS 
before further centrifugation and flash freezing in 
liquid nitrogen. 5g of frozen cells were ground to 
powder under liquid nitrogen and added to 15 ml 
50 mM Tris, pH 7.5, 1% SDS containing 1 μM E-
64 (Sigma), 1 COMPLETETM protease inhibitor 
tablet (Roche) and 100 μl Plant Protease inhibitor 
cocktail (Sigma). The suspension was agitated for 
30 minutes at 4ºC before centrifugation at 10,000g 
for 20 minutes at 4ºC. The supernatant was 
removed and heated in SDS-PAGE sample buffer 
at 65ºC for 3 minutes before immediate analysis by 
Western blotting as previously described 
Isolation of membrane and organelle fractions 
from cell cultures- Sucrose density gradient and 
assay of fractions were performed as described 
[35]. For total membrane isolation, cells (2g) were 
collected by filtration onto nitro-cellulose filters. 
They were ground to a fine powder in presence of 
liquid nitrogen and resuspended in 10 ml of 
homogenisation buffer, (25 mM Hepes / KOH. pH 
7.5, 300 mM Sucrose, 1mM DTT, 2 mM o-
phenanthroline, 1.4 μg/L Pepstatin, 0.5μg/L 
Leupeptin, 2 μg/L aprotinin, and 1 μg/L Trans-
epoxysucinyl-L-Leucylamido- (4-guanido)-
butane). The homogenate was filtered through one 
layer of Miracloth (Calbiochem) followed by two 
layers of gauze. The filtered homogenate was 
centrifuged at 5,000 g for 15 minutes at 4ºC. The 
5,000g supernatant was centrifuged at 100,000 g 
for 1 hour at 4ºC to separate total membranes 
 3
(pellet) from the cytosol (supernatant). Western 
blotting was carried out as previously described. 
Anti-His6T7PEX19 serum was used at 1:5,000-
1:10,000 dilution. Anti-thiolase serum was used at 
1:50,000 dilution. 
Co-immunoprecipitation- His6T7PEX19 and 
PEX10 (in pGEM-T easy) were transcribed and 
translated in a coupled wheatgerm lysate system 
(TNT) in the presence of [35S] L-methionine 
according to the manufacturers (Promega) 
protocol. After 90 minutes at 30ºC, equal volumes 
(25μl) of His6T7PEX19 and PEX10 translation 
reactions were mixed and incubated for a further 
90 minutes at 30ºC then immunoprecipitated with 
either non immune antiserum or anti poly-His 
antiserum. Siliconized tubes were used to avoid 
non-specific binding of radio-labelled proteins. 
Twenty two microlitres of each reaction were 
diluted into 0.55 ml IP buffer (50 mM Tris HCl pH 
7.5, 150 mM NaCl, 5mM EDTA, 1% v/v Triton-
X-100, plus 1 COMPLETE™ protease inhibitor 
cocktail tablet (Roche) per 50 ml) with 50 μl of 
protein A beads (prewashed in IP buffer) and 
incubated with gentle shaking at 4ºC for 1 hour. 
The beads were removed by centrifugation and the 
supernatants removed to a clean tube and anti-
serum (1:50 dilution) added and incubated 60 
minutes 4ºC with gentle agitation. A further 50 μl 
protein A beads were added and incubated as 
before. Immunoprecipitated proteins were 
recovered by centrifugation and the beads 
extensively washed in IP buffer. The final washed 
pellet was resuspended in SDS-PAGE sample 
buffer and solubilised at 37oC for 60 minutes 
before SDS-PAGE and detection by 
phosphoimaging. 
 
RESULTS 
 
 Arabidopsis thaliana has two PEX19-like 
genes- The Arabidopsis thaliana genome contains 
two reading frames At5g17550 and At3g03490 
with significant homology to human Pex19p 
(28.2% amino acid identity) and Saccharomyces 
cerevisiae Pex19p (24.5% amino acid identity) 
(Fig. 1). An EST (ATTS4952 GI:773437) 
corresponding to At3g03490, which we have 
designated AtPEX19-1 was fully sequenced 
(accession number AJ564199). AtPEX19-1 and 
AtPEX19-2 are 82% identical to one another at the 
nucleotide level and 79% identical at the amino 
acid level.  All four proteins share conserved 
CAAX box motifs at the carboxyl terminus. In 
addition there are two regions that are particularly 
well conserved. The first is a block of 13 
alternating acidic and hydrophobic residues near 
the amino terminus that are predicted to form a 
perfect acidic amphipathic helix 
(http://www.site.uottawa.ca/~turcotte/resources/He
lixWheel/) and a second region in the C-terminal 
half of the protein that also shares alternating polar 
and hydrophobic residues and a predicted helical 
structure (Fig. 1). Using the secondary structure 
prediction program GOR4, Arabidopsis PEX19 is 
estimated to be predominantly α-helical (58%) 
with a substantial proportion of random coil 
(36.7%) [36]. Our circular dichroism (CD) analysis 
of recombinant His6PEX19 indicated 25-50% 
helix, 9-27% strand, 14-24% turn and 27-30% 
unordered structures depending on the method and 
reference set to fit the data (data not shown). 
To determine whether both genes were 
expressed, gene specific primers were designed 
and used in a reverse-transcription PCR reaction 
with total RNA derived from different Arabidopsis 
tissues. Both genes are expressed in essentially all 
tissues including seedlings, roots, young and 
senescent leaves, flowers, siliques and stems (data 
not shown). To obtain a more detailed expression 
profile, public microarray data derived from the 
Affymetrix 22k chip was analysed using the 
GENEVESTIGATOR web site 
(https://www.genevestigator.ethz.ch/[37]). 
AtPEX19-2 (At5g17550) is not present on the 22k 
chip so only results for AtPEX19-1 are presented 
(Fig. 2). PEX19-1 is most highly expressed in 
young seedlings, age 1-5.9 days, corresponding to 
stage 0.1-0.70 [38]. Levels then remain fairly 
constant throughout development before increasing 
as the plants produce seeds (stage 8). Consistent 
with this, the highest level of expression is in 
stamens and seed. High levels are also seen in cell 
suspension cultures (Fig. 3A). 
  Arabidopsis PEX19 is a predominantly 
cytosolic protein- Antibodies were raised against 
recombinant His6T7PEX19, which detected a 
protein of about 30 kDa in 2 day Arabidopsis 
seedlings (Fig. 3A, lane 3 left panel). This protein 
was absent when the antibodies were preincubated 
with the recombinant His6T7PEX19 (Fig. 3A right 
panel). The antibody readily detected 10 and even 
1 ng of recombinant His6T7PEX19 which has a 
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molecular weight of 31,842 (Fig. 3A left panel 
lanes 1 and 2). Due to the high degree of similarity 
between PEX19-1 and PEX19-2 we assume the 
antibody detects both isoforms in plant samples 
and therefore refer to the cross-reacting band as 
AtPEX19. To determine the localisation of 
AtPEX19 in Arabidopsis cells we used a 
suspension culture cell line. These suspension 
culture cells have abundant peroxisomes as shown 
by electron microscopy (data not shown). 
Suspension culture cells were fractionated into a 
total membrane and soluble fraction and probed 
with anti-PEX19 antibodies. PEX19 was recovered 
predominantly in the cytosol (Fig. 3B lane C), with 
only a small proportion associated with the 
membrane fraction. (Fig. 3B lane M). Sucrose 
density gradient centrifugation was used to prepare 
organelle fractions from tissue culture cells. The 
position of peroxisomes was determined by 
immunoblotting with the marker protein thiolase 
(Fig. 3C top panel). This shows that intact 
peroxisomes are found predominantly in fractions 
4-7 with a substantial amount of thiolase found at 
the top of the gradient, which represents protein 
that has been released from damaged organelles. A 
duplicate blot was probed with anti PEX19 
antibodies, where native PEX19  (Fig. 3C lower 
panel, arrow) was mainly found at the top of the 
gradient with a minute amount co-sedimenting 
with peroxisomes, although there is a prominent 
doublet that is enriched in the peroxisomal 
fractions that migrates with approximately twice 
the expected molecular weight of PEX19 (Fig. 3C 
lower panel). Thus it is thought that AtPEX19 is 
predominantly cytosolic. 
 Arabidopsis PEX19 forms a dimer- 
His6PEX19 was over expressed as a soluble 
protein in E. coli. The recombinant protein was 
purified to near homogenetiy using nickel affinity 
chromatography, with a molecular mass 
determined by matrix assisted laser 
desorption/ionisation mass spectrometry to be 
30,479 (not shown), which was consistent with the 
calculated mass. However, when analysed by gel 
filtration chromatography, the purified protein was 
shown to elute with a retention volume 
corresponding to a protein of approximately 60 
kDa (Fig. 4 A). This was determined by 
comparison to molecular weight calibration 
proteins. The data suggests that PEX19 forms a 
dimer which is extremely stable, since little 
monomeric protein was observed. When analysed 
by SDS-PAGE, rHis6PEX19 migrated with an 
apparent molecular mass of slightly greater than 30 
kDa consistent with denatured, monomeric 
polypeptide chains (Fig. 4 B). 
 In vitro translated and recombinant 
PEX19 binds PEX10- In other organisms Pex19p 
binds to a range of PMPs including Pex10p [17]. 
The ability of AtPEX19 to bind to AtPEX10 was 
tested via co-immunoprecipitation (Fig. 5). In vitro 
translations of the individual full length proteins 
were mixed, incubated together for 90 minutes at 
30ºC then were subjected to immunoprecipitation 
under non-denaturing conditions with either non-
immune serum (PI) or anti His antibody (H). 
PEX10 (open arrow) was clearly co-
immunoprecipitated with His6T7PEX19 (solid 
arrow) when anti-His tag antibody was used, but 
not when a non-immune serum was substituted for 
the primary antibody. PEX10 was equally 
efficiently precipitated with His6T7PEX19 
regardless of whether the proteins were translated 
separately and mixed or translated together (data 
not shown).  
 To establish whether the recombinant 
His6PEX19 was able to bind PEX10, pull down 
experiments were performed. As full length 
AtPEX10 is unlikely to be soluble when expressed 
in E. coli, a fusion protein, GST–PEX10267-381 was 
constructed. This corresponds to the region of 
PEX10, C-terminal to the predicted second 
transmembrane domain and includes the entire 
RING finger. Lysates from E. coli cells expressing 
GST-PEX10267-381 or His6PEX19 were applied 
singly, or as a mixture, to glutathione columns. 
The unbound material was collected and the 
column washed prior to elution with glutathione. 
The fractions were analysed by Western blotting 
using antibodies against His6T7PEX19 and GST 
(Fig. 6). Where lysate containing His6PEX19 was 
applied to the GST column on its own, (Fig. 6A 
middle panel) His6PEX19 was recovered in the 
flow through (FT) and wash (W) fractions but not 
in the eluate fraction (E). However, when lysate 
containing PEX19 was mixed with lysate 
containing GST-PEX10267-381, a portion of PEX19 
was recovered in the glutathione eluate (Fig. 6 A, 
right most panel, lane E). When GST-PEX10267-381 
alone was applied to the column, as expected there 
was no PEX19 immunoreactivity in any fraction 
(Fig. 6A left most panel). A duplicate blot to that 
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shown in Fig. 6A was probed with anti-GST 
antibodies (Fig. 6B). GST-PEX10267-381 binds to 
the column and is eluted with glutathione (Fig. 6B 
left and right most panels). When His6PEX19 
alone was applied to the column, no 
immunoreactivity was detected at the molecular 
weight corresponding to PEX19 (compare Fig. 6A) 
showing that the anti-GST antibodies do not cross 
react with PEX19 These results demonstrate that 
PEX19 is only retained on the glutathione column 
in the presence of GST-PEX10267-381. Therefore 
both in vitro translated and recombinant PEX19 
bind to PEX10. 
 PEX19 binds to other proteins as a dimer 
in vivo- To examine the binding characteristics of 
Arabidopsis PEX19 in vivo, whole suspension cell 
culture cells were cross-linked using 1% 
formaldehyde and the cell lysate analysed by 
Western blotting (Fig. 7). Evidence that PEX19 
binds to other proteins was apparent, since when 
subjected to the crosslinking procedure, the 
majority of the protein migrated down the gel with 
apparent masses of greater than 160 kDa, 
suggesting that binding complexes made with 
other proteins were rendered permanent by the 
procedure (Fig. 7A). Native PEX19 from the non-
crosslinked cells migrated with molecular masses 
of approximately 30 and 60 kDa consistent with 
monomeric and dimeric protein. Interestingly, the 
band corresponding to the dimer was not observed 
in the crosslinked sample (Fig. 7A, left lane), 
indicating that the dimer may be preferentially 
involved in the formation of complexes with other 
proteins. To eliminate the possibility that the band 
thought to be a dimer in the non-crosslinked 
sample, is a result of non-specific binding by the 
antisera, samples were also analysed by Western 
blot using antisera incubated with 10 μg 
recombinant His6PEX19 prior to 
immunodecoration of the blot (Fig. 7B). It must be 
noted that in Fig. 4B, recombinant His6PEX19 
migrated in SDS-PAGE only as an apparent 
monomer with mass of approximately 30 kDa, 
even though gel filtration chromatography 
indicated that the protein has a dimeric mass of 60 
kDa. The fact that dimer was not seen on this SDS-
PAGE, but was observed in the crosslinking study 
(Fig. 7 A), can be attributed to incomplete 
denaturing in SDS-PAGE sample buffer prior to 
loading the gel. In the crosslinking study, samples 
were heated to 65ºC in order to limit proteolytic 
action of native Arabidopsis enzymes, but were not 
boiled in order to minimise thermally induced 
aggregation of possible membrane protein-PEX19 
complexes in the presence of SDS [39]. However, 
since samples collected from the gel filtration 
column were unlikely to contain membrane 
proteins, they were boiled in sample buffer for 3 
minutes. 
 
 
DISCUSSION 
 
In this study we have characterised PEX19 from 
Arabidopsis thaliana. There are two genes 
encoding very similar PEX19 isoforms, both of 
which are expressed. Analysis of microarray data 
for PEX19-1 shows expression in a range of cell 
types and developmental stages consistent with a 
requirement for maintenance of peroxisomes in a 
wide range of tissues. High levels of expression in 
cell suspension culture probably reflects the 
rapidly dividing nature of this undifferentiated 
tissue, whereas high levels of expression in seed is 
consistent with the requirement of peroxisomes for 
embryogenesis. Like its counterparts in mammals 
and yeasts, AtPEX19 is a predominantly cytosolic 
protein with only a small portion of the membrane-
associated fraction migrating with peroxisomes, 
suggesting that the interaction with the peroxisome 
membrane is quite labile. 
 Conservation of structure between 
Arabidopsis and human PEX19 is apparent. Like 
human Pex19p [31], we also found that 
recombinant AtPEX19 is readily cleaved by 
thrombin and trypsin, resulting in a fragment of 20 
kDa which is extremely stable to further digestion 
and which likely corresponds to the C-terminus 
(data not shown). Alignment of the sequences of 
the human and Arabidopsis PEX19s reveal that the 
lysine residue which was determined to be the 
trypsin cleavage site [31] is conserved in both 
AtPEX19-1 and AtPEX19-2. Secondary structure 
prediction using the program GOR4 [36] gives 
values of 58% alpha helix and 37% random coil 
for AtPEX19-1. CD analysis on purified 
His6PEX19 also indicated a fairly high proportion 
(27-30%) of unordered structure. However, our 
CD data for the full length PEX19 protein 
indicates a much higher content of α-helix (25-
50% depending on the method and reference set 
used to fit the data) than the 22% reported by for 
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human Pex19p [31], as well as significant amounts 
of strand (9-27%) and turn (14-24%).  
 On gel filtration we found that His6PEX19 
elutes with a retention volume corresponding to a 
molecular size of 60 kDa, although SDS-PAGE 
and MALDI-MS indicate only a single polypeptide 
chain, consistent with the calculated mass of 
His6PEX19 and AtPEX19-1. The elution profile is 
very symmetric indicating a uniform population of 
molecules. Shibata et al [31] favoured the 
interpretation that the anomalous migration of 
human Pex19p on gel filtration was due to ‘a 
certain distorted shape, caused by the disordered 
N-terminal region’. We think a more likely 
explanation is that PEX19 forms a stable dimer. 
Indeed on SDS-PAGE gels we often see a varying 
amount of a molecular species that reacts with 
anti-PEX19 antibody and is approximately twice 
the molecular weight of the monomeric PEX19. In 
Fig. 7 we show that this species is preferentially 
cross-linked in vivo and forms large heterogeneous 
complexes. As PEX19 is a relatively small protein 
it may function as a homo or hetero oligomer to 
keep large hydrophobic PMPs in solution. 
Interestingly Otzen et al. [24] showed by 
fluorescence correlation spectroscopy and native 
gels that Hansenula polymorpha Pex19p-GFP is 
detected in complexes of approximately 250 kDa. 
This is consistent with a homotetramer of 60 kDa 
HpPex19p-GFP molecules, although this 
interpretation is complicated by the fact that GFP 
itself has a tendency to dimerise at high 
concentrations [40]. 
 Like its mammalian and yeast counterparts 
AtPEX19 binds the peroxisome membrane protein 
PEX10. The GST pull down experiments 
demonstrate that there is a binding site for PEX19 
within the C terminus of AtPEX10. This is in line 
with previous results that showed that the region 
between amino acids 217 and 380 of Pichia 
pastoris Pex10p interacted with Pex19p in the 
yeast 2 hybrid system [17]. As the recombinant 
AtPEX19 is not farnesylated, the pull down 
experiments demonstrate that farnesylation is not 
required for PEX10 binding and that this 
interaction can take place post translationally. 
However this does not exclude the possibility that 
PEX19 can interact with nascent PMPs or that 
farnesylation could enhance or regulate PMP 
binding. 
 Recently Pex19p binding sites were 
identified and characterised in S. cerevisiae for 
Pex13p and ScPex11p and their importance for 
correct targeting in vivo demonstrated [28]. The 
essential features of these sites are that they are 
short 11mer linear peptides, most likely α-helical 
in nature and containing both hydrophobic and 
basic residues. How might these be recognised by 
PEX19? The alignment in Fig. 1 reveals two 
strikingly conserved regions between human, S. 
cerevisiae and Arabidopsis PEX19’s. These two 
regions consist of alternating hydrophobic (shaded 
gray) and polar, often acidic, residues. For the 
Arabidopsis proteins both regions are predicted to 
lie within regions of alpha helix. Thus they would 
make attractive possibilities to bind a positively 
charged helical peptide. A similar molecular 
recognition event occurs between Tom20, a 
mitochondrial import receptor and the positively 
charged amphipathic α-helical mitochondrial-
targeting signal. Tom20 binds the hydrophobic 
face of the peptide [41] and is also presumed to 
bind the charged face due to the presence of 
negatively charged domains within this protein 
[42]. Interestingly, when PEX19 is deleted or 
mutated several PMPs are mistargeted to 
mitochondria [21, 24], suggesting that in the 
absence of PEX19, the PEX19 binding motif could 
be recognised by the mitochondrial targeting 
machinery.  
 The integral peroxisome membrane 
protein PEX3 functions as a receptor for PEX19, 
where docking is thought to facilitates the insertion 
of the PMP cargo [29]. Our data together with 
recent publications from other groups allow us to 
propose a model for PEX19 function which 
provides an explanation for the two independent 
binding sites within PEX19 for PEX3 [30, 32]. The 
PEX3 binding site within the amino terminus of 
PEX19 has been mapped to the first 51 residues of 
human PEX19 [29] and first 42 residues of Pichia 
Pex19p [17]. This would encompass the highly 
conserved negatively charged amphipathic helix 
shown in Fig. 1, which is also a feature of the two 
Arabidopsis PEX19 proteins. This N-terminal 
region of PEX19 can interact with human PEX3 in 
the region 120-136 [29] (italics in Fig. 8A), and 
with yeast Pex3p in the region 130-160 predicted 
from the PEX19 binding site algorithm [28] 
(underlined in Fig. 8A), thereby providing the 
docking function for PEX19 at the peroxisome 
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membrane [29] (Fig. 8A). There is a second site in 
PEX19 which binds both PMPs and PEX3 [30] 
which overlaps the second conserved region in 
PEX19 (Fig. 1). This binding site must interact 
with a second PEX19 binding site in PEX3, which 
lies within the first 66 amino acids of human 
PEX3, because a naturally occurring splice variant 
of human PEX19 which lacks the first 87 amino 
acids of PEX19 can bind full length PEX3 but not 
the N terminal truncation [32]. Consistent with this 
Rottensteiner et al [28] predict a second Pex19p 
binding site within amino acids 25-50 of 
Saccharomyces Pex3p (underlined in Fig. 8A). 
This encompasses a region that contains a number 
of charged and hydrophobic residues. We propose 
that this N-terminal region of PEX3, which would 
lie close to the membrane surface (or possibly even 
on the membrane surface as amphipathic helix), 
would compete with the mPTS of the PMP cargo 
for binding to the second PEX19 binding site. This 
would release the mPTS and associated TMD in 
the vicinity of the membrane, where it could either 
insert spontaneously or integrate catalysed by 
PEX3 or some as yet unidentified factor. The 
function of PEX19 as a dimer would make sense, 
as many PMPs have two or more mPTS. Dimeric 
PEX19 could bind a PMP with two mPTS’s and 
deliver these for release at the membrane surface 
allowing insertion of the two transmembrane 
domains as a helical hairpin. Dimeric PEX19 could 
in principle interact with one molecule of PEX3 
sequentially, or two molecules of PEX3 
simultaneously. 
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FIGURE LEGENDS 
 
Fig. 1. Arabidopsis contains two homologues of HsPEX19. Alignment of Arabidopsis PEX19-1 and 19-2 
with human PEX19 and Saccharomyces cerevisiae PEX19. Amino acid sequences were aligned with the 
programme T-COFFEE [43]. Grey shading indicates hydrophobic residues in conserved regions that are 
predicted to form amphipathic helices. The CAAX motif directing farnesylation is indicated in bold. The 
cleavage site for trypsin in human PEX19 is indicated by an arrow. 
 
Fig. 2. Expression profiles of Arabidopsis PEX19-1. Expression profiles were constructed from public 
microarray data using tools available on the GENEVESTIGATOR website [37]. A, Expression in various 
plant organs generated by the Gene Atlas tool. B, Expression at different developmental stages, defined by 
[38]. Stage 0, seed germination; stage 1, leaf development; stage 3, rosette growth; stage 5, inflorescence 
emergence; stage 6, flower production; stage 8, silique development generated by the gene chronologer 
tool. 
 
Fig. 3. Arabidopsis PEX19 is predominantly a cytosolic protein. A, Anti-PEX19 antibodies recognise 
native PEX19, a 30 kDa protein in Arabidopsis seedlings. Left panel, immunoblot probed with anti-
PEX19 anti-serum 1:10,000 dilution; lane 1, 10 ng recombinant His6T7PEX19, lane 2, 1 ng 
His6T7PEX19, lane 3, total protein extract equivalent to twenty 2 day old Arabidopsis seedlings. Right 
panel, as for left panel except that the anti-PEX19 antiserum was preincubated with 10 μg His6T7PEX19 
prior to immunodecoration of the blot. B. PEX19 is mainly cytosolic. Tissue culture cells were separated 
into a cytosolic fraction (100,000 x g supernatant), lane 1 and a membrane associated fraction (100,000 x 
g pellet), lane 2 and probed with anti-PEX19 serum. C. An organelle fraction prepared from tissue culture 
cells was separated by sucrose density gradient centrifugation and the fractions blotted and detected with 
anti-thiolase (top panel) and anti-PEX19 (lower panel). The star indicates a recombinant His6T7PEX19 
standard in lane 1. The arrow indicates the native PEX19. 
 
Fig. 4. Recombinant His6PEX19 forms a dimer.  A, rHis6PEX19 (previously purified by nickel affinity 
chromatography, data not shown) was applied to a gel filtration column and eluted with a retention 
volume of 115 ml (shown by downward pointing arrow) indicating it has a mass of 60 kDa, consistent 
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with a dimer. The column was calibrated using a gel filtration low molecular weight calibration kit (GE 
Health Care) with retention volumes and masses of the protein standards indicated on the chromatogram 
(upward pointing arrows). V0 is the void volume. B, Coomassie stained SDS-PAGE of rHis6PEX19 in 
fractions eluted from the gel filtration column. His6PEX19 in fractions between 110 and 135 ml (indicated 
by hatched double arrows on A and B) show that it migrates with an apparent mass of approximately 30 
kDa in SDS-PAGE, despite elution from the column with a mass of approximately 60 kDa. The lane 
indicated as P shows rHis6PEX19 before gel filtration chromatography. 
 
Fig. 5. In vitro translated AtPEX19-1 interacts with PEX10. His6PEX19-1 and PEX10 were in vitro 
translated and mixed (lane B) prior to immunoprecipitation by non-immune serum (PI) or anti-His 
antibodies (H) followed by SDS-PAGE and phosphoimaging. Solid arrow indicates the position of 
PEX19-1, open arrow indicates the position of PEX10. 14C Molecular weight standards are indicated. 
 
Fig. 6. Recombinant His6PEX19 binds to the C-terminus of PEX10. Pull down experiments using lysates 
from E. coli expressing His6PEX19 (PEX19) or GST-PEX10267-381 (PEX10) were performed; The lysates 
were applied alone or as a mixture of both, to a glutathione column, the flow through collected, column 
washed and specifically bound material was eluted with 10 mM reduced glutathione. The fractions (P, 
sample prior to column application, FT, flow through, W, wash and E, eluate) were analysed by Western 
blot, immuno-stained with anti-PEX19 (panel A) or anti-GST (panel B) antibodies. Positions of 
His6PEX19 (panel A) and GST-PEX10267-381 (panel B) are indicated by arrows  
 
Fig. 7. The dimeric form of PEX19 is preferentially cross-linked to other proteins in vivo. Arabidopsis 
suspension cells were cross-linked in vivo with 1% formaldehyde. A, The cell lysates, cross-linked, (lane 
+) or not cross-linked (lane -), were examined by immunoblotting using antiserum raised against 
recombinant His6PEX19 at 1:10,000 dilution. B, As panel A, but the antisera was incubated with 
rHis6PEX19 (10  μg) for 30 minutes at 37ºC before immunodecoration of the blot. 
 
Fig. 8. The possible interactions of PEX19 and PEX3 in the targeting and insertion of PMPs. A, Clustal W 
alignment of PEX3 sequences from Arabidopsis, human and S. cerevisiae. Underlined, predicted binding 
sites for ScPex19p, italics, experimentally determined binding site for HsPEX19. B, Model showing the 
possible roles of the two PEX19 binding sites (BS) of PEX3 and the two PEX3 binding sites on PEX19 in 
the targeting and insertion of PMPs (shown in orange). The interaction between the N-terminal PEX3 
binding site on PEX19 and the second PEX19 binding site on PEX3 provides the docking interaction. We 
propose that the function of the second PEX19 binding site on PEX3 is to displace the mPTS in the 
vicinity of the membrane. Membrane insertion may then be spontaneous, catalysed by PEX3 or another 
unknown factor (not shown). 
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AtPEX19-1       --------MAN-S--HTDDLDELLDSALDDFKDLNLSHQRNQREAQEEEEKKRKEETVLL 
AtPEX19-2       --------MANDT--HTDDLDELLDSALDDFKDLNLT----QRNGGVKKEEGDKKETESL 
HsPEX19         MAAAEEGCSVGAE--ADRELEELLESALDDFDKAKPSPAPPSTTTAPDASGPQKRSPGDT 
ScPEX19         MPNIQHEVMNENEYDNFDDLDDLLDEDPTKLDEAEPDDVQAKGSVYNDSENKEKNAESKD 
                                  :*::**:.   .:.. :      .     . .   *.      
 
AtPEX19-1       PSGVQ------------------------------------------------------- 
AtPEX19-2       PSGVQ------------------------------------------------------- 
HsPEX19         AKDALFASQEKFFQELF------------------------------------------- 
ScPEX19         SDGVQVANESEEDPELKEMMVDLQNEFANLMKNNGNENNVKTEDFNKLISALEEAAKVPH 
                ....                                                         
 
AtPEX19-1       -GLGMGLPDMRSKKRGKQKVSKEDH-----VAEALDKLREQT-----------------R 
AtPEX19-2       -GLGMGLPDMRSKKKGKKKIAKEDH-----VTEALDKLREQT-----------------R 
HsPEX19         DSELASQATAEFEKAMKELAEEEPH-----LVEQFQKLSEAAGRVGSDMTSQQEFTSCLK 
ScPEX19         QQMEQGCSSLKSNSTDKGTVNGSNPGFKNIVSNTLDRLKENG-----------------N 
                     . .  . :.  *     .       : : :::* *                   . 
                                           ↓ 
AtPEX19-1       ETVKGLESISSKQLPASDDDGMVEDFLKQFED----------L-----AGSKDLESIVET 
AtPEX19-2       ETVKGLESLSSKQQPTGSDDAMVEDWIKQFEN----------L-----TGSNDLESIVDT 
HsPEX19         ETLSGLAKNATDLQNSSMSE---EELTKAMEG----------LGMDEGDGEGNILPIMQS 
ScPEX19         KVDTSLAEETKESQRSGQN-NNIDDILSQLLDQMVASGGKESAENQFDLKDGEMDDAITK 
                :. ..* . :..   :. .    ::  . : .                  . ::   : . 
 
AtPEX19-1       MMQQLLSKDILHEPMKELGARYPKWLKEN-EASLSKEDYKRYSQQYKLIEELNAVYE--- 
AtPEX19-2       MMQQLLSKDILHEPMKEIGARYPKWLEEH-ESSLNKEEFDRYSRQYELIKELNLVYE--- 
HsPEX19         IMQNLLSKDVLYPSLKEITEKYPEWLQSH-RESLPPEQFEKYQEQHSVMCKICEQFE--- 
ScPEX19         ILDQMTSKEVLYEPMKEMRSEFGVWFQENGENEEHKEKIGTYKRQFNIVDEIVNIYELKD 
                ::::: **::*: .:**:  .:  *::.: . .   *.   *..*..:: ::   :*    
 
AtPEX19-1       -NEPNNSSK---------IMEIMQKMQECGQPP--------------SDIVKEIDPGFDF 
AtPEX19-2       -NEPNNSTK---------IMEIMQKMQECGQPP--------------SDIVQEMDPGFDF 
HsPEX19         -AETPTDSETTQKARFEMVLDLMQQLQDLGHPP--------------KELAGEMPPGLNF 
ScPEX19         YDELKHKDR---------VTELLDELEQLGDSPIRSANSPLKHGNEEEELMKMLEIDGND 
                  *   . .         : :::::::: *..*              .::   :  . :  
 
AtPEX19-1       -ASLGQISPEMLESSPNCCIM 
AtPEX19-2       -ASLGQMSPDMLESSPNCCVM 
HsPEX19         DLDALNLSGPPGASGEQCLIM 
ScPEX19         -PNLGNLDKELTDGCKQQ--- 
                  .  ::.     .  :     
 
 
Figure 1 
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AtPEX3          ---MDFVRGFWRKHRRKVLVTAGCLGSGYLLYK----LYNSHTRRLADLERELAHEREND
HsPEX3          --MLRSVWNFLKRHKKKCIFLGTVLGGVYILGK----YGQKKIREIQ--EREAA-----E
ScPEX3          MAPNQRSRSLLQRHRGKVLISLTGIAALFTTGSVVVFFVKRWLYKQQ--LRITE-----Q
.: ::*: * :.    :.. :   .      :    .   *        :
AtPEX3          EIIKTQMKAHFESIQMIVDSTTLPHAMQFLSIRISEE-IDVSHVMDRLNQG---------
HsPEX3          YIAQARRQYHFESNQRTCNMTVLSM-LPTLREALMQQ-LN-SESLTALLKN---------
ScPEX3          HFIKEQIKRRFEQTQEDSLYTIYEL-LPVWRMVLNENDLN-LDSIVTQLKDQKNQLTRAK
: : : : :**. *     *     :      : :: ::  . :   :.         
AtPEX3          --KGMLSPP--EKLQLWDELKILSFTRMVLSLWSVTMLSLYIRVQVNILGRHLYVDTARA
HsPEX3          --R----PS--NKLEIWEDLKIISFTRSTVAVYSTCMLVVLLRVQLNIIGGYIYLDNAAV
ScPEX3          SSESRESSPLKSKAELWNELELKSLIKLVTVTYTVSSLILLTRLQLNILTRNEYLDSAIK
.    ..  .* ::*::*:: *: : .   ::.  * :  *:*:**:    *:*.* 
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